JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.46B |
| 2 |
Microsoft
MSFT
|
+$2.83B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.33B |
| 5 |
Stryker
SYK
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.18B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.39B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.35B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.04% |
| 2 | Technology | 20.48% |
| 3 | Healthcare | 9.65% |
| 4 | Financials | 9.27% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2851
Privia Health
PRVA
$2.59B
| $5.79M | ﹤0.01% |
251,432
-876
| -0.3% | -$19.6K |
2021 Q2
10 quarters
|
|
2852
Sensient Technologies
SXT
$5.47B
| $5.78M | ﹤0.01% |
87,547
-47,679
| -35% | -$2.82M |
2013 Q2
42 quarters
|
|
2853
Sight Sciences
SGHT
$470M
| $5.77M | ﹤0.01% |
1,117,633
+68,853
| +7% | +$212K |
2021 Q3
9 quarters
|
|
2854
BioLife Solutions
BLFS
$1.82B
| $5.77M | ﹤0.01% |
354,800
-19,541
| -5% | -$249K |
2019 Q2
18 quarters
|
|
2855
PUT
Johnson Controls International
JCI
$94.6B
| $5.76M | ﹤0.01% |
+100,000
| New | +$5.25M |
2023 Q4
0 quarters
|
|
2856
CALL
TSMC
TSM
$2.45T
| $5.76M | ﹤0.01% |
55,400
-23,600
| -30% | -$2.25M |
2020 Q3
13 quarters
|
|
2857
Global X Cybersecurity ETF
BUG
$2.01B
| $5.76M | ﹤0.01% |
196,496
+20,461
| +12% | +$528K |
2022 Q1
7 quarters
|
|
2858
Progress Software
PRGS
$1.51B
| $5.75M | ﹤0.01% |
105,939
-16,602
| -14% | -$880K |
2013 Q2
42 quarters
|
|
2859
PUT
Skyworks Solutions
SWKS
$12.8B
| $5.74M | ﹤0.01% |
51,100
+25,400
| +99% | +$2.49M |
2021 Q3
9 quarters
|
|
2860
Walker & Dunlop
WD
$1.17B
| $5.74M | ﹤0.01% |
51,696
-1,534
| -3% | -$126K |
2014 Q1
39 quarters
|
|
|
CIM
2861
Chimera Investment
CIM
$775M
| $5.73M | ﹤0.01% |
382,706
+62,401
| +19% | +$942K |
2013 Q2
42 quarters
|
|
2862
American Vanguard Corp
AVD
$51.3M
| $5.72M | ﹤0.01% |
521,840
+310,434
| +147% | +$3.09M |
2013 Q2
42 quarters
|
|
2863
CALL
Buckle
BKE
$2.21B
| $5.72M | ﹤0.01% |
+120,400
| New | +$4.56M |
2023 Q4
0 quarters
|
|
2864
PUT
ScottsMiracle-Gro
SMG
$2.85B
| $5.69M | ﹤0.01% |
+89,200
| New | +$4.82M |
2023 Q4
0 quarters
|
|
|
STR
2865
DELISTED
Sitio Royalties
STR
| $5.69M | ﹤0.01% |
241,864
+94,528
| +64% | +$2.19M |
2019 Q1
19 quarters
|
|
|
DNB
2866
DELISTED
Dun & Bradstreet
DNB
| $5.69M | ﹤0.01% |
485,900
-69,335
| -12% | -$706K |
2020 Q4
12 quarters
|
|
2867
Patria Investments
PAX
$1.65B
| $5.62M | ﹤0.01% |
362,543
+4,576
| +1% | +$64.9K |
2021 Q1
11 quarters
|
|
2868
CALL
Celsius Holdings
CELH
$6.77B
| $5.59M | ﹤0.01% |
+102,600
| New | +$5.48M |
2023 Q4
0 quarters
|
|
|
ESPR
2869
DELISTED
Esperion Therapeutics
ESPR
| $5.57M | ﹤0.01% |
1,862,470
-1,862
| -0.1% | -$2.42K |
2015 Q3
33 quarters
|
|
2870
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.59B
| $5.57M | ﹤0.01% |
77,167
+9,850
| +15% | +$669K |
2013 Q2
42 quarters
|
|
2871
iShares Micro-Cap ETF
IWC
$1.4B
| $5.57M | ﹤0.01% |
47,980
+3,949
| +9% | +$400K |
2017 Q1
27 quarters
|
|
2872
First Trust Institutional Preferred Securities and Income ETF
FPEI
$1.86B
| $5.56M | ﹤0.01% |
+312,106
| New | +$5.33M |
2023 Q4
0 quarters
|
|
2873
Tyra Biosciences
TYRA
$1.4B
| $5.56M | ﹤0.01% |
401,706
+4,088
| +1% | +$52.9K |
2021 Q4
8 quarters
|
|
2874
Radiant Logistics
RLGT
$439M
| $5.56M | ﹤0.01% |
837,189
+51,914
| +7% | +$315K |
2017 Q4
24 quarters
|
|
2875
PUT
Snowflake
SNOW
$120B
| $5.53M | ﹤0.01% |
27,800
+24,200
| +672% | +$4.09M |
2020 Q4
12 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2023 Portfolio in Review
As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase's Q4 2023 filing shows 701 new, 3,661 increased, 2,247 reduced and 617 closed positions. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M. The largest sale was Vanguard S&P 500 ETF, an estimated $3.18B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
- JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
- JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
- JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
- JP Morgan Chase opened 701 new positions and closed 617 in Q4 2023.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.